Revascularization for Severe Disabling Claudication

Rationale for Revascularization

• The American College of Cardiology recommends revascularization as a reasonable treatment option for patients with functionally limiting claudication and inadequate response to guideline-directed medical therapy, with a Class 2a, Level B-R evidence rating 1, 2
• The American College of Cardiology states that endovascular revascularization is effective (Class 1, Level A evidence) to improve walking performance and quality of life for patients with hemodynamically significant aortoiliac disease and functionally limiting claudication 1, 2
• Iliac artery stenting provides similar durability to surgical revascularization with lower periprocedural risk, according to the American College of Cardiology 3, 4
• The American College of Cardiology recommends surgical endarterectomy as a reasonable option (Class 2a, Level B-R) for patients with hemodynamically significant common femoral artery disease and inadequate response to guideline-directed medical therapy 1, 2

Inpatient Stay Medical Necessity

• The American College of Cardiology supports inpatient observation for patients undergoing combined iliac stenting and common femoral endarterectomy, due to the need for hemodynamic monitoring, assessment of distal perfusion, wound care, and pain management 1, 2, 5, 7
• A 1-2 day inpatient stay is reasonable for combined iliac stenting and common femoral endarterectomy, according to the American College of Cardiology, to allow for overnight monitoring, assessment of procedural success, and initiation of antiplatelet therapy 5, 7, 8

Risk-Benefit Analysis

• The American College of Cardiology emphasizes weighing potential benefits (quality of life, walking performance, functional status) against risks and durability, and supports revascularization for patients with severe disabling claudication and inadequate response to medical therapy 1, 2
• The American College of Cardiology acknowledges that perioperative risks are acceptable given the severity of disability, and that the risk of restenosis does not preclude intervention in symptomatic patients 1, 6

Criteria Alignment

• The patient meets criteria for revascularization according to the MCG Cardiovascular Surgery GRG, with severe disabling claudication and severe disability from ischemia present 1, 2
• The patient meets criteria for percutaneous revascularization according to the MCG S-1310, with in-stent restenosis in a previously stented patient documented 4
• The patient meets criteria for revascularization according to the 2024 ACC/AHA Guidelines, with functionally limiting claudication, inadequate response to guideline-directed medical therapy, hemodynamically significant disease, and a favorable risk-benefit ratio 1, 2, 6